Industry Trends: July 2021

Tuesday, July 13, 2021

Glycomics/Glycobiology Market Size and Analysis, Trends, Recent Developments, and Forecast Till 2028

Increasing glycomics research, rising investment in drug discovery and development, and growing opportunities in biopharmaceutical sector are key factors driving market growth

Glycomics/Glycobiology Market Size – USD 1.0 Billion in 2020, Market Growth – at a CAGR of 14.1%, Market Trends – Growing demand for advanced glycomics and glycobiology tools

The latest market study by Reports and Data, titled ‘Global Glycomics/Glycobiology Market,’ is a comprehensive analysis of the Glycomics/Glycobiology industry that involves detailed study of each of the market segments. The market intelligence report is an exhaustive study of this industry and precisely forecasts the future growth opportunities and trends of this business sphere. The report endows the reader with an in-depth analysis of the Glycomics/Glycobiology market dynamics, including the key drivers, opportunities, threats, and challenges likely to impact the market development over the projected period. The report is inclusive of quantitative and qualitative studies of the Glycomics/Glycobiology market and zeroes in on the key aspects of the market, such as the product portfolios, pricing structure, industry trends, end-user industries, sales statistics, distribution channels, and top manufacturers.

Top Companies Profiled in the Report:

Thermo Fisher Scientific, Inc. Merck KGaA, Agilent Technologies Bruker Corporation, New England Biolabs, Danaher, Shimadzu Corporation, Takara Bio, Inc., Asparia Glycomics S.L, and ProZyme.

According to Reports and Data, the global Glycomics/Glycobiology market is expected to register a robust revenue growth rate over the forecast period. The report elaborates on the key business strategies, demand and supply ratios, leading market regions, and the renowned players and their respective company portfolios. In addition, the report offers a futuristic outlook of the Glycomics/Glycobiology industry and highlights the key players’ gross profits, revenue shares, sales volume, manufacturing costs, individual growth rate, and their financial standing. It further describes the developmental scope of the new entrants and established companies of the Glycomics/Glycobiology market over the projected years, while analyzing their market positions using advanced tools like Porter’s Five Forces Analysis, SWOT analysis, and investment assessment. The report sheds light on the most significant business strategies adopted by established market players to strengthen their market positions. Moreover, the global Glycomics/Glycobiology industry report comprehensively studies the present global health crisis and its profound impact on the global economic landscape. The Glycomics/Glycobiology industry growth has been majorly hampered by the ongoing COVID-19 pandemic, which has disrupted its functioning and growth possibilities. However, the global Glycomics/Glycobiology industry is projected to regain momentum in the post-COVID-19 years.

For more details on the report, visit @ https://www.reportsanddata.com/report-detail/glycomics-glycobiology-market

The latest research report offers a complete analysis of the macroeconomic and microeconomic factors accountable for the global Glycomics/Glycobiology market development. The report also concentrates on the regulatory framework that is shaping the future of the global market. New and existing pricing structures, emerging application areas, and upcoming investment opportunities have also been detailed in the report. The report also highlights the commonly used marketing and promotional strategies adopted by the key market players. Taking into account the existing market development factors, historical events, and recent market trends, the study presents a balanced opinion on the future scenario of the global Glycomics/Glycobiology market. It thus supports its opinion by discussing the key corporate strategies, such as mergers & acquisitions, takeovers, joint ventures, and strategic alliances, used by the market players to strengthen their global footprint.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3986

Segmentation of the Global Glycomics/Glycobiology Market:

Product Outlook (Revenue, USD Billion; 2018-2028)

Enzymes

Glycosidases & Neuramidases
Glycosyltransferases & Sialytransferases
Others

Instruments

Mass Spectrometry Instruments
Chromatography Instruments
Arrays
Others

Kits

Glycan Releasing Kits
Glycan Labelling Kits
Glycan Purification Kits
Others

Reagents

Application Outlook (Revenue, USD Billion; 2018-2028)

Drug Discovery & Development
Diagnostics
Others

End-use Outlook (Revenue, USD Billion; 2018-2028)

Academic Research Institutes
Pharmaceutical and Biotechnology Companies
CROs
Others

REgional Segmentation of the Global Glycomics/Glycobiology Market:

North America
Latin America
Europe
Middle East & Africa
Asia Pacific

Key Points Covered in The Regional Section:

Regional contribution
Estimated revenue generation
An expected rise in market share
Forecast growth in the overall consumption rate
Vital data and information about the consumption rate in all the leading regional segments

Global Glycomics/Glycobiology Market: Competitive Outlook

The global Glycomics/Glycobiology market report studies market growth trajectories of the leading companies operating in this industry. According to our team of market experts, these companies hold a considerable portion of the overall market share. The key strategic initiatives led by these companies, including mergers & acquisitions, joint ventures, new business deals, new product launches, collaborations, technological upgradation, and several others, have been described under this section of the report.

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/3986

Thank you for reading our report. To receive further information on the report or to enquire about its customization, please get in touch with us and get your report tailored according to your needs.

Medical Imaging Workstations Market Size and Analysis, Trends, Recent Developments, and Forecast Till 2028

Growing preference for digital platforms, rising prevalence of various diseases, and increasing adoption of medical imaging workstations are key factors fueling market growth

Market size: USD 1.07 Billion in 2020, Market Growth: CAGR of 9.2%, Market Trends: Steady transition from traditional diagnostics methods to highly developed automated systems for disease diagnosis

The Global Medical Imaging Workstations Market size is expected to reach USD 2.14 billion by 2028 and register a CAGR of 9.2%, according to the latest report by Reports and Data. Growing adoption of medical imaging workstations and rising prevalence of diabetes, cancer, stroke, and cardiovascular disorders are a few key factors boosting global market revenue growth.

Medical imaging workstations have become an important part of diagnostic centers and healthcare systems in recent years. These systems have inbuilt software which automates the entire process and helps in diagnosing various types of diseases and reducing manual workflow. Technological developments in medical imaging systems, such as 3D and 4D, have increased demand for medical imaging workstations globally. Increasing investments by market players and governments to support product development, commercialization of products, and growing inclination toward digital platforms are some key factors boosting market revenue growth. Moreover, favorable reimbursement scenarios for preventive diagnosis and increasing number of outpatient and ambulatory imaging facilities are further boosting market growth. Besides, various market players are investing in R&D activities to develop and launch advanced products and strengthen their market position, which is expected to create new growth opportunities.

Ask for Sample Report @ https://www.reportsanddata.com/sample-enquiry-form/4103

However, dearth of skilled professionals, lack of awareness about these medical imaging workstations, and high costs of procedure are some key restraints expected to hamper market growth to some extent during the forecast period.

To identify the key trends in the industry, click on the link Some key highlights in the report:

Among component segments, the display units segment is expected to account for fastest revenue growth throughout the forecast period. Fast revenue growth is attributed to rapid adoption of medical display units towing to its enhanced ability to provide better display systems.
Based on usage mode, the thin client workstations segment is expected to account for substantial revenue growth during the forecast period owing to factors such as increasing need for early and accurate diagnosis of diseases and easy setup.
Among the application segments, the advanced imaging segment is projected to account for large market share between 2021 and 2028 due to several benefits offered by these systems such as high quality of images and low possibilities of duplicate imaging.
North America is expected to dominate other regional markets in the global medical imaging workstations market during the forecast period. Factors, such as availability of high funds for research and development activities, increasing investments by private and public sectors, and presence of robust market players, are fueling market growth in this region.
Asia Pacific is expected to register fastest CAGR over the forecast period which is attributable to factors including growing demand for advanced imaging, high investments by market players and government for R&D activities, and increasing cases of chronic disorders considering large population pool.
General Electric Company (US), Koninklijke Philips N.V. (Netherlands), Siemens AG (Germany), Fujifilm Holdings Corporation (Japan), Canon Medical Systems Corporation (Japan), Carestream Health (US), Hologic (US), Carl Zeiss Meditec AG (Germany), Accuray Incorporated (US), Capsa Healthcare (US), Ampronix (US), Medicor Imaging (US), NGI Group (France), Alma IT Systems (Spain), and Pie Medical Imaging (Netherlands) are the major players operating in the global medical imaging workstations market.

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/4103

For this study, Reports and Data has segmented the global medical imaging workstations market based on Modality, Component, Usage Mode, Application, Clinical Specialty, and Region:

Modality Outlook (Revenue, USD Billion, 2018 - 2028)

Magnetic Resonance Imaging (MRI)
Computed Tomography (CT)
Ultrasound
Mammography
Other Modalities

X-ray
Angiography
Radiotherapy
Nuclear Imaging Systems

Component Outlook (Revenue, USD Billion, 2018 - 2028)

Visualization Software
Display Units
Display Controller Cards
Central Processing Units

Usage Mode Outlook (Revenue, USD Billion, 2018 - 2028)

Thin Client Workstations
Thick Client Workstations

Application Outlook (Revenue, USD Billion, 2018 - 2028)

Diagnostic Imaging
Clinical Review
Advanced Imaging

Clinical Specialty Outlook (Revenue, USD Billion, 2018 - 2028)

Oncology
Cardiology
General Imaging/Radiology
Obstetrics and Gynecology
Orthopedics
Mammography
Urology
Other Clinical Specialties

Hepatology
Neurology
Dentistry
Bariatric Surgery
Respiratory Care
Emergency Care

Regional Outlook (Revenue, USD Billion, 2018 - 2028)

North America

U.S.
Canada
Mexico

Europe

Germany
U.K.
France
Italy
Rest Of Europe

Asia Pacific

China
India
Japan
South Korea
Rest of APAC

Latin America

Brazil
Rest of LATAM

Middle East & Africa

Saudi Arabia
UAE
South Africa
Rest of MEA

To know more about the report @ https://www.reportsanddata.com/report-detail/medical-imaging-workstations-market

Key Benefits of the Report:

Comprehensive overview of the changing dynamics of competitive landscape
Detail oriented futuristic prospects of factors driving and restraining growth of the market
Valuable insights on key market growth driving trends and monetary competence in the forecast period
Strategic recommendations to key players and new entrants to overcome barriers and challenges in the market
Revenue forecasts for the period of 2020-2028

Thank you for reading our report. Customization of the report is available based on the client’s requirements. For more details, kindly connect with us, and our team will ensure the report is suited to meet your requirements.

Nucleic Acid Isolation and Purification Market Revenue, Major Players, Consumer Trends, Analysis & Forecast Till 2028

Increasing advancement in genomics research, rising adoption of sequencing techniques in clinical diagnostics, and growing investment in R&D in molecular biology and precision medicine are key factors driving market growth

Market Size – USD 3.19 Billion in 2020, Market Growth – at a CAGR of 8.6%, Market Trends – Increasing use of nucleic acid-based tests in diagnostics

The Global Nucleic Acid Isolation and Purification Market size is expected to reach USD 6.17 Billion by 2028 at a CAGR of 8.6%, according to the latest report by Reports and Data. Rapid adoption of nucleic-based tests in clinical diagnostics, growth in genomics research, increasing use of sequencing techniques to identify and diagnose diseases, and rapid technological advancements in biotechnology and pharmaceutical sectors are some key factors expected to drive market revenue growth over the forecast period. In addition, increasing investment in research and development in the fields of molecular biology and precision medicine are also expected to drive revenue growth of the market over the forecast period.

Ask for Sample Report @ https://www.reportsanddata.com/sample-enquiry-form/3968

Nucleic acid isolation and purification is a routine procedure in molecular biology and forensic analysis. Nucleic acid is a starting point for numerous downstream applications and the quality of nucleic acids in the sample play a major role in determining the success of subsequent steps of analysis. Nucleic acid extraction and purification is majorly done to disintegrate cell envelope and achieve maximal removal of lipids and proteins to obtain high-quality and yield and DNA or RNA. The nucleic acid samples generated by this technique are then used for various purposes such as in sequencing, cloning, polymerase chain reaction, and others. It enables efficient identification and detection of pathogens, microorganism, and genetic aberrations in the given sample. This has contributed significantly to progress of genomics research and is expected to further fuel revenue growth of the market over the forecast period.

Increasing application of Next-Generation Sequencing (NGS) and liquid biopsies for early detection and diagnosis of cancer is also expected to boost revenue growth of the market going ahead. However, lack of skilled technicians, incidence of nucleic acid degradation, and high costs of reagents and instruments are expected to restrain market growth to a certain extent over the forecast period.

Some Key Highlights From the Report:

The kits and reagents segment is expected to account for significant revenue share in the global market during the forecast period owing to increasing use of reagents and kits during DNA and RNA isolation procedures, rising demand during research studies, and increasing convenience of kits and reagents.
Magnetic beads segment is expected to register considerable revenue growth over the forecast period owing to increasing use of magnetic beads in isolation and purification techniques due to its ability to improve assay performance and generate high-quality nucleic samples.
RNA isolation and purification segment is expected to register significant revenue CAGR over the forecast period owing to increasing need for RNA isolation for COVID-19 diagnostics and rising use of mRNA for constructing cDNA library.
Diagnostics segment is expected to register significant revenue growth over the forecast period owing to increasing application of DNA and RNA isolation for identifying pathogens and microorganisms in samples.
Hospitals and diagnostic centers segment revenue is expected to expand considerably over the forecast period owing to increasing demand for early screening and diagnosis of diseases and infections in a cost-efficient, accurate, and time-efficient manner.
North America is expected to account for largest revenue share in the global market over the forecast period owing to rising technological advancement, growing investment in biotechnology research, and robust presence of key players in the region.
Major companies operating in the market include QIAGEN N.V., Thermo Fisher Scientific, Roche AG, Merck KGaA, Agilent Technologies Inc., Illumina, Inc., Takara Bio, Inc., Promega Corporation, GE Healthcare, Danaher Corporation, New England Biolabs, and Bio-Rad Laboratories.
In October 2020, Purigen Biosystems, Inc. introduced Ionic Cells to Pure DNA Low Input Kit to help researchers study genetic diseases in limited biological samples. The automated 60-minute workflow produces high-quality DNA samples for study of genetic abnormalities and assessment of treatment response to disease.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/3968

For the purpose of this report, Reports and Data has segmented the global nucleic acid isolation and purification market based on product, type, method, application, end-use industry, and region:

Product Outlook (Revenue, USD Billion; 2018-2028)

Kits & Reagents
Instruments

Method Outlook (Revenue, USD Billion; 2018-2028)

Column
Magnetic Beads
Others

Type Outlook (Revenue, USD Billion; 2018-2028)

Genomic DNA isolation and purification
Plasmid DNA isolation and purification
RNA isolation and purification
miRNA isolation and purification
Others

End-use Industry Outlook (Revenue, USD Billion; 2018-2028)

Hospitals & Diagnostics Centers
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
CROs
Others

Regional Outlook (Revenue, USD Billion; 2018-2028)

North America
- US.
- Canada
- Mexico
Europe
- Germany
- UK.
- Italy
- France
- BENELUX
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
Latin America
- Brazil
- Rest of LATAM
Middle East & Africa
- Saudi Arabia
- A.E.
- South Africa
- Rest of MEA

Connect with an expert for customization of Report @ https://www.reportsanddata.com/request-customization-form/3968

Reasons to invest in this report:

To gain a thorough, in-depth understanding of the global Nucleic Acid Isolation & Purification Market.
To study the latest trends and projected growth rate over the forecast timeline.
To assist the industry specialists, market investors, and stakeholders line up their market-centric strategies to make profits.
To acquire well-informed insights to make correct business decisions.
To conduct a competitive analysis of major market participants of the industry.

Spatial Genomics & Transcriptomics Market Size and Analysis, Trends, Recent Developments, and Forecast Till 2028

Technological advancements in sequencing technologies, increasing application of spatial genomics and transcriptomics in biomarker identification and drug discovery, and increasing funding to expand R&D activities are key factors driving revenue growth of market

Market Size – USD 178.4 Million in 2020, Market Growth – at a CAGR of 18.1%, Market Trends – Increasing prevalence of genetic disorders globally

The Global Spatial Genomics & Transcriptomics Market size is expected to reach USD 675.34 Million by 2028 at a CAGR of 18.1% over the forecast period, according to the latest report by Reports and Data. Key factors driving market revenue growth include increasing prevalence of genetic disorders and chronic conditions such as cancers, neurological disorders, and rare diseases, which have boosted need for high-resolution multiplex assays and instruments, and this is expected to further drive developments in spatial-based technologies. Increasing application of spatial genomics and transcriptomics for drug discovery and biomarker identification is also a key factor expected to drive revenue growth of market over the forecast period. Significant funding to expand R&D activities in the field of spatial-based technology is expected to support market growth going ahead.

Spatial transcriptomics covers methods specifically designed to assign cell types to their specific locations across tissue samples. It allows determination of subcellular localization of mRNA molecules. Data obtained about spatial distribution of mRNA molecules allows researchers to study cellular heterogeneity in tissues, tumors, and immune cells. Spatial-profiling based solutions allows analysis of tissue microenvironment, tumor biology, and tissues biomarkers. Spatial genomics and transcriptomics offers key insights in the fields of oncology, immunology, cell and gene therapy, histology, and embryology.

Ask for Sample Report @ https://www.reportsanddata.com/sample-enquiry-form/3964

Spatial genomics and transcriptomics are novel research fields that aim to fill the knowledge gap about cellular machinery, spatial organization, differentiations, and localization that occurs at genomic and transcriptomics level within each cell and in tissues. These techniques have significant potential in managing chronic and rare diseases and rising burden of chronic disease such as cancers and diabetes across the globe have boosted their application in drug discovery and development. This is expected to fuel revenue growth of market over the forecast period. However, lack of skilled professionals and low awareness about advanced spatial-based technologies can restrain market growth to a significant extent over the forecast period.

Some Key Highlights from the Report:

Spatial transcriptomics segment revenue growth is expected to expand steadily over the forecast period owing to increasing transcriptomic studies of single cells for drug discovery and development and increasing demand for advanced sequencing techniques.
Consumables segment is expected to register significant revenue growth over the forecast period, attributable to increasing availability of a wide range of products, high penetration rate of consumable, and rising expenditure on reagents and kits for efficient functioning of instruments.
Translational research segment is expected to account for a significant revenue share in the global market during the forecast period owing to increasing application of spatial genomics and transcriptomics in translational research to understand high-throughput data of cells and tissues to understand disease pathology and physiology.
Academic & research institute segment is expected to register significant revenue CAGR over the forecast period owing to increasing adoption of spatial genomic and transcriptomic analysis in academic institutions, increasing focus on diseases pathology, and availability of funding and grants for genomic and transcriptomic research.
North America is expected to account for largest revenue share contribution to the global market over the forecast period, attributable to increasing investment to advance genomic R&D initiatives, rising focus on disease pathology research, and technological advancements in biomedical techniques and sequencing technologies. Robust presence of key companies in the region is also expected to support market growth going ahead.
Key companies operating in the market include 10X Genomics, NanoString Technologies Inc., Illumina Inc., Bio-Rad Laboratories, Natera Inc., S2 Genomics, Inc., Dovetail Genomics, Bio-Techne, Flagship Biosciences, Fluidigm Corporation, Seven Bridges Genomics, Horizon Discovery Group Plc., and Akoya Biosciences, Inc., among others.
In April 2021, Vizgen, which is a U.S-based biotech company that develops solutions for next-generation spatially resolved, single cell transcriptomics, closed Series B funding round at USD 37 Million, which will be used to accelerate infrastructure development for the commercial launch of MERSCOPE Platform to advance spatial genomics research. The platform offers insights into a broad range of tissue-based research and translation medicine in neurology, oncology, and immunology, among others.

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/3964

For the purpose of this report, Reports and Data has segmented the global spatial genomics & transcriptomics market based on technique, product application, end-use industry, and region:

Technique Outlook (Revenue, USD Million; 2018-2028)

Spatial Genomics
- Fluorescence In Situ Hybridization (FISH)
- Sequencing Techniques
- Others Spatial Genomics Analysis Techniques
Spatial Transcriptomics
- Immunohistochemistry (IHC)
- In Situ Hybridization
- Sequencing Technologies
- Microscopy-based RNA Imaging
- Other Spatial Transcriptomics Techniques

Product Outlook (Revenue, USD Million; 2018-2028)

Instruments
Consumables
Software

Application Outlook (Revenue, USD Million; 2018-2028)

Translational Research
Drug Discovery & Development

End-user Outlook (Revenue, USD Million; 2018-2028)

Academic & Research Institutions
Contract Research Organizations (CROs)
Pharmaceutical and Biotech Companies
Others

Regional Outlook (Revenue, USD Million; 2018-2028)

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- U.K.
- Italy
- France
- BENELUX
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
Latin America
- Brazil
- Rest of LATAM
Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Rest of MEA

To know more about the report @ https://www.reportsanddata.com/report-detail/spatial-genomics-and-transcriptomics-market

Rheometers And Viscometers Market Revenue, Major Players, Consumer Trends, Analysis & Forecast Till 2027

Increasing use of rheometers and viscometers in research and diagnostic laboratories and expanding chemical and petrochemical industries is boosting market growth

Market Size – USD 791.62 million in 2020, Market Growth – at a CAGR of 4.3%, Market Trends – Rising adoption of automated laboratory systems

The Global Rheometers And Viscometers Market size is expected to reach USD 1,087.57 million by 2028 at a CAGR of 4.3%, according to the latest report by Reports and Data. Steady market revenue growth is primarily attributed to technological advancements in rheometers and viscometers, rapidly surging demand among various end-use industries including pharmaceutical and biotechnology, cosmetics, and food & beverage industries, and from petrochemical refineries, and chemical and material manufacturers, and due to wide usage of these devices in research and diagnostic laboratories.
Rheometers and viscometers are devices extensively used by a number of end-use industries for measuring the viscosity and rheological properties of various fluid samples such as liquids, polymers, suspensions, glass formers including silicates, slurry flows, or bodily fluids such as blood. Viscometers, on the other hand, are devices that measure and analyze the viscosity of different types of fluids.

Ask for Sample Report @ https://www.reportsanddata.com/report-detail/rheometers-and-viscometers-market

Viscometers and rheometers are widely employed in the petrochemical and food & beverage industries, as they measure the engine oil flow under different temperatures and determine the viscosity of food products such as honey, jams, and syrups. In addition, considerable investments in R&D activities in food & beverage, pharmaceutical, and cosmetics industries, rising focus on laboratory automation, and increasing demand for high-quality pharmaceutical and cosmeceutical products are other significant market growth-influencing factors. Stringent government norms regarding the quality check of food and drug products is a factor further expected to propel global market growth going ahead.

Some Key Highlights from the Report:

The viscometers segment is expected to remain the leading product type segment in terms of revenue share over the forecast period. Extensive use of viscometers across research and diagnostic laboratories and pharmaceutical and food & beverage industries, increasing use of blood viscometers in cardiovascular disease diagnosis and treatment, and advantages of these devices such as faster processing time, higher accuracy and versatility, and ease of handling are key factors driving revenue growth of this segment.
Petroleum product manufacturers & petrochemical refineries segment is expected to lead in terms of revenue share among the other end-use segment over the forecast period. Rapidly growing petrochemical industry and rising demand for rheometers and viscometers for petroleum production processes are some factors projected to boost revenue share of this segment.
The North America rheometers and viscometers market accounted of largest revenue share in 2020, and is expected to maintain its dominance over other regional markets over the forecast period. Expanding pharmaceutical, cosmetics, food & beverage, and petrochemical industries and rising applications of rheometers and viscometers in research and diagnostic procedures are some key factors driving market growth.
The key players operating in the global rheometers and viscometers market include Thermo Fisher Scientific, Brookfield Engineering Laboratories, Anton Paar, Lamy Rheology Instruments, Cannon Instrument Company, Waters Corporation, Bartec Group, Shimadzu Corporation, Emerson, GBC Scientific Equipment Pty Ltd., Goettfert, Petroleum Analyzer Company LP (PAC LP), Spectris, Dynisco, and Hydramotion.

To know more about the report @ https://www.reportsanddata.com/report-detail/rheometers-and-viscometers-market

For the purpose of this report, the global rheometers and viscometers market has been segmented based on product type, sample type, end-use, and region:

By Product Type (Revenue, USD Million; 2018-2028)

Rheometers
- Dynamic Rotational Rheometers
- Torque Rotational Rheometers
- High-throughput Rheometers
- Oscillatory Rheometers
- Capillary Rheometers
- Others
Viscometers
- Rotational Viscometers
- Capillary Viscometers
- Process Viscometers
- Others

By Sample Type (Revenue, USD Million; 2018-2028)

Suspensions & Slurries
Resins & Coatings
Pastes & Gels
Others

By End-user (Revenue, USD Million; 2018-2028)

Pharmaceutical, Biotechnology, and Cosmeceutical Companies
Research Laboratories and Academic Institutes
Petroleum Product Manufacturers & Petrochemical Refineries
Chemical and Material Manufacturers
Food and Beverage Manufacturers
Paints & Coatings Manufacturers
Others

By Region (Revenue, USD Million; 2018-2028)

North America
- U.S.
- Canada
Europe
- Germany
- U.K.
- France
- BENELUX
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Rest of the Asia Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa
- Saudi Arabia
- UAE
- Rest of the Middle East & Africa

Connect with an expert for customization of Report @ https://www.reportsanddata.com/request-customization-form/3942

Reasons to invest in this report:

To gain a thorough, in-depth understanding of the global Rheometers and Viscometers Market
To study the latest trends and projected growth rate over the forecast timeline.
To assist the industry specialists, market investors, and stakeholders line up their market-centric strategies to make profits.
To acquire well-informed insights to make correct business decisions.
To conduct a competitive analysis of major market participants of the industry.

Monday, July 5, 2021

Natural Language Processing (NLP) in Healthcare and Life Sciences Market– Challenges, Drivers, Outlook, Segmentation - Analysis to 2026

Natural Language Processing (NLP) in Healthcare and Life Sciences Market

The latest research on the Natural Language Processing (NLP) in Healthcare and Life Sciences Market fundamentally delivers insights that can empower stakeholders, business owners, and field marketing executives to make effective investment decisions driven by facts and extremely thorough research. The study aims to provide an evaluation and deliver essential information on the competitive landscape to meet the unique requirements of the companies and individuals operating in the Natural Language Processing (NLP) in Healthcare and Life Sciences Market for the forecast period, 2020–2027. To help firms comprehend the Natural Language Processing (NLP) in Healthcare and Life Sciences industry in multiple ways, the report exhaustively assesses the share, size, and growth rate of the business worldwide.

Request For Free PDF Sample Of This Research Report At: https://www.reportsanddata.com/sample-enquiry-form/2558

This is the most recent report, covering the current economic situation after the COVID-19 outbreak. This has brought along some major changes in the economy. The current scenario of the ever-evolving business sector and present and future appraisal of the effects are covered in this report.

Various research techniques are applied to produce data on competitors’ strategies; past, present and future sales and purchasing trends. Business owners aiming to inspect the present consumer base and reaching the target audience will be able to leverage the demographic details derived from different regions, to infer dynamic market shifts. Perspectives on different disruptive forces that are believed to have a transformative influence on the future sales make the document valuable. Insights on where the Natural Language Processing (NLP) in Healthcare and Life Sciences Market should be heading during the forecast years from 2020–2027. The report also sheds light on how major vendors are transforming the business today.

In market segmentation by manufacturers, the report covers the following companies-

Cerner Corporation, 3M, Nuance Communications, Inc., IBM Corporation, Heath Fidelity, Microsoft Corporation, Linguamatics, Apixio, Clinithink Inc., and Mmodal IP PLC., among others.

Purchase Complete Natural Language Processing (NLP) in Healthcare and Life Sciences Market Research Report At:

The study predicts what the future Natural Language Processing (NLP) in Healthcare and Life Sciences Market can be expected to witness. The research also familiarizes product owners with immediate threats in the market, buyer’s requirements, and the effective business strategies implemented by prominent industry players. The report aims to help both existing companies and new entrants not only prepare against the disruption but also see opportunities. In-depth examination of market trends, including the assessment of government bodies, financial organization, and other regulatory bodies. Starting with a macroeconomic outlook, the study performs a detailed examination of the sub-categories of the industry and the trends that have an impact on the business.

For this report, Reports and Data have segmented into the global Natural Language Processing (NLP) in Healthcare and Life Sciences market on the basis of resin type, application techniques, industry vertical, and region:

Component Type Outlook (Revenue, USD Billion; 2020-2027)

Service
Technology

Type Outlook (Revenue, USD Billion; 2020-2027)

Statistical NLP
Rule-Based NLP
Hybrid NLP

Deployment Mode Type Outlook (Revenue, USD Billion; 2020-2027)

On-Premise
Cloud

Application Type Outlook (Revenue, USD Billion; 2020-2027)

Machine Translation
Predictive Risk Analytics
Report Generation
Automated Information Extraction
Others

Get Your Copy at Discounted Price@ https://www.reportsanddata.com/discount-enquiry-form/2558

Regional Outlook (Volume, Kilo Tons and Revenue, USD Billion; 2020-2027)

North America
Europe
Asia Pacific
MEA
Latin America

The research provides answers to the following key questions:

What will be the marketing and pricing strategies adopted by prominent vendors operating in the Natural Language Processing (NLP) in Healthcare and Life Sciences Market for the forecast years from 2020 to 2027?
What are the new uses for the existing products or services and how have they contributed towards increasing the demand for products or services?
What are the general conditions prevailing and influencing the business environment of the Natural Language Processing (NLP) in Healthcare and Life Sciences Market?
Who are the key manufacturers venturing into new geographies to establish a lucrative market their products and services?
What will be the dynamics of the demand and supply and the requirements of the distribution channel across the globe in the near future?
What will be the market share of the Natural Language Processing (NLP) in Healthcare and Life Sciences industry over the considered time periods?

Request For Customization Of This Research Report At: https://www.reportsanddata.com/report-detail/natural-language-processing-nlp-in-healthcare-and-life-sciences-market

The latest Natural Language Processing (NLP) in Healthcare and Life Sciences Market intelligence report provides business owners, stakeholders and field marketing executives’ critical insights about the opportunities as well as strengths to help keep up with the dramatic shift in the consumer behavior and consumption power.

Thank you for reading the article. You can also get individual chapter-wise or region-wise section in the report

Endometriosis Market Swot Analysis, Porters Five Forces Analysis, Forecast Till 2027

Increasing awareness about women's health, increasing occurrence rate of the condition, the rising focus on clinical trials are some of the factors boosting the endometriosis market.

Market Size – USD 1.93 Billion in 2018, Market Growth - CAGR of 2.8%, Market Trends –The increasing focus on clinical trial.

The Global Endometriosis Market is forecast to reach USD 2.42 Billion by 2026, according to a new report by Reports and Data. Endometriosis is the resultant of the growth of endometrial tissue on bowel, ovaries, and tissues lining the pelvis. The hormonal changes associated with the menstrual cycle impacts the misplaced endometrial tissue that results in the area to become inflamed that causes pain. It implies that the tissue will thicken, grow, and break down. With time, the tissue that broken down has nowhere to go and becomes trapped in pelvis.

The market is projected to witness considerable growth during the forecast period. One of the mentionable factors in this regards being, the increasing occurrence rate of the condition. It has turned out to be a common gynecological condition, affecting approximately 10% of women. Treatment for the disease is dependent on the severity of the disease, symptoms, and if the care user wishes to have children. The condition is treatable with surgery, medication, or both. Medication is usually tried first when pain is the primary problem.

Ask for Sample Report @ https://www.reportsanddata.com/sample-enquiry-form/2553

Medications that are prescribed to treat the condition include pain relievers like nonsteroidal anti-inflammatory drugs (NSAIDs), and hormonal medications, including gonadotropin-releasing hormone agonists and birth control pills, progestin. Hormonal medications help minimize the growth of the endometrial tissue and may prevent the formation of new adhesions. Though it is mentionable that, these drugs are usually not effective in getting rid of endometriosis tissue that is already there. In regards to surgical options, Conservative surgery like Laparoscopy, hysterectomy are some of the available options.

In context to region, Europe occupies a prominent market position. The market position held by the region is resultant of the continuous growth of the healthcare sector and rising investment in the industry.

Further key findings from the report suggest

· The endometriosis market held a market share of USD 1.93 Billion in the year 2018 and forecasted to grow at a rate of 2.8% during the forecast period.

· In regards to Drug Type, the NSAID’s segment generated the highest revenue of USD 0.58 Billion in 2018, with a growth rate of 2.9% during the forecast period. The effectiveness of the medicine in relieving pain caused by the condition, which are nonsteroidal anti-inflammatory drugs that work by discontinuing the release of prostaglandins that is one of the main chemicals resulting in the pain, contributes to the revenue generated by the NSAID’s segment.

· In context to Surgery Type, the Laparoscopy segment yielded the highest revenue of USD 0.87 Billion in 2018, with the fastest growth rate of 3.2% during the forecast period. The effectiveness of this surgery in accurately diagnosing endometriosis and even eliminate it in mild-moderate condition with just a small incision resulted in its increased demand and revenue generated by the

· In regards to the End-users, the Drugstores segment can be seen to occupy the largest market share of 30.2% in 2018, with the second-highest growth rate of 3.1% during the forecast period. The fact that in most cases of endometriosis, pain in the primary issue, in which medication is the first choice, has resulted in high dependency on drugstores for availing the prescribed medication, which contributes to the market share occupied by this segment.

· In context to region, Asia Pacific is projected to witness the fastest growth rate of 5.5% during the forecast period, which occupied the second-largest market share of 24.3% in 2018. The growth rate experienced by the Asia Pacific region is resultant of continuous growth in healthcare technology and the rising awareness about women’s health.

· Key participants include Johnson & Johnson Services Inc., Bayer AG, Neurocrine Biosciences Inc., Meditrina Pharmaceuticals Inc., AbbVie Inc., Astellas Pharma Inc., AstraZeneca Plc, Evotec AG, Debiopharm Group and Teva Pharmaceutical Industries Ltd.

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2553

For the purpose of this report, Reports and Data have segmented the global endometriosis market based on Surgery Type, Drug Type, End-Users, and region:

Surgery Type Outlook (Revenue, USD Billion; 2016-2026)

· Laparoscopy

· Laparotomy

· Pelvic nerves surgery

Drug Type Outlook (Revenue, USD Billion; 2016-2026)

· NSAID’s

· Gonadotropins Releasing Hormone Agonists

· Progestin

· Oral Contraceptive Pills

End-Users Type Outlook (Revenue, USD Billion; 2016-2026)

· Hospital

· Pharmacies

· Drugstores

· E-commerce

Regional Outlook (Revenue, USD Billion; 2016-2026)

· North America

o U.S

· Europe

o U.K

o France

· Asia Pacific

o China

o India

o Japan

· MEA

· Latin America

o Brazil

To know more about the report @ https://www.reportsanddata.com/report-detail/endometriosis-market

Key Features of the Endometriosis Market Report:

· The report encompasses details about the key companies, product portfolio along with specifications, production valuation, and market shares

· Extensive study of key segments and sub-segments of the Endometriosis market

· Evaluation of key current and emerging market trends and growth prospects

· Brief overview of industry with regards to research and development, technological advancements, and product development

· In-depth assessment of upstream raw materials, downstream buyers, demands, and current market scenario

· Analysis of key drivers, restraints, opportunities, growth prospects, limitations, and threats

· Strategic recommendation to key players and new entrants to overcome entry-level barriers in the Endometriosis market over the forecast period

Table of Content:

Chapter 1. Market Synopsis
1.1. Market Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2018-2026
Chapter 3. Indicative Metrics
Chapter 4. Endometriosis Market Segmentation & Impact Analysis
4.1. Endometriosis Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Increasing awareness about women health
4.2.2.2. Increasing occurrence rate of the condition
4.2.2.3. The rising focus on clinical trials
4.2.3. Market restraints analysis
4.2.3.1. Lack of awareness about the preventive measures and causes for the disease
4.3. Technological Insights
4.4. Regulatory Framework
4.5. ETOP Analysis
4.6. Porter’s Five Forces Analysis
4.7. Competitive Metric Space Analysis
4.8. Price trend Analysis
Chapter 5. Endometriosis Market By Surgery Type Insights & Trends

Continued….

Industry Trends